Cassava Sciences Inc (SAVA) soared 29.47% for July 21

Equities Staff  |

Cassava Sciences Inc (NASDAQ: SAVA) shares soared 29.47%, or $26.77 per share, to close Wednesday at $117.60. After opening the day at $94.58, shares of Cassava fluctuated between $120.75 and $94.30. 9,271,038 shares traded hands an increase from their 30 day average of 3,042,115. Wednesday's activity brought Cassava’s market cap to $4,705,017,710.

Cassava is headquartered in Austin, Texas..

About Cassava Sciences Inc

Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer's disease.

Visit Cassava Sciences Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Cassava Sciences Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Cassava Sciences Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Market Movers

Sponsored Financial Content